The Use of Fractional Exhaled Nitric Oxide (FENO)in the Clinical Management of Asthma
Details
Expires Saturday March 12th, 2011
Price: $ FREE!Pre-Registration: Available
To register for this topic, read the following disclosures and
then click the Enroll button at the bottom of the page.
Description

The following White Paper presents points of clinical consensus arrived at by participants in a closed meeting held at National Jewish Health in Denver, Colorado. The meeting took place on July 20, 2009. The group of clinicians and researchers, all leaders in the field of asthma, met to discuss the utility of FENO in the diagnosis and management of asthma. The following represents a summary of their presentations, discussions and recommendations.This meeting was funded by an unrestricted educational grant from Aerocrine.

Moderator: David Tinkelman, MD, National Jewish Health, Denver, CO

Presenters:

Peter Boggs, MD
The Asthma Allergy Clinic, Shreveport, LA

Neal Jain, MD
Dean Health System, Madison, WI

Miguel Lanz, MD
AAADRS Clinical Research Center, Coral Gables, FL

Stanley Szefler, MD
National Jewish Health, Denver, CO

Discussants:

Kaiser Lim, MD
Mayo Clinic, Rochester, MN

Andrew Liu, MD
National Jewish Health, Denver, CO

Harold Nelson, MD
National Jewish Health, Denver, CO

Jeffrey Rosch, MD
Penn State Milton S. Hershey Medical Center, Hershey, PA

Download Consensus Panel White Paper.

Faculty Disclosures
No disclosures provided.